A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535])
Clinical trial NCT01537757 · COMPLETED
Trial details
- NCT number
- NCT01537757
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2012-05-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.